Patents by Inventor Jae Yul Choi

Jae Yul Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME
    Publication number: 20230002358
    Abstract: Provided are a pyrimidine compound represented by Formula 1, a method of preparing the compound, and a pharmaceutical use of the compound for the prevention or treatment of cancer.
    Type: Application
    Filed: January 25, 2022
    Publication date: January 5, 2023
    Inventors: In Hwan BAE, Ji Sook KIM, Jae Yul CHOI, Seok Jong KANG, Young Gil AHN, Kwee Hyun SUH
  • PHARMACEUTICAL COMPOSITION FOR TREATING ACUTE MYELOID LEUKEMIA, CONTAINING FLT3 INHIBITOR AND CHEMOTHERAPEUTIC AGENTS
    Publication number: 20220354842
    Abstract: Provided are: a pharmaceutical composition for treating myeloid leukemia (AML), and a method for treating acute myeloid leukemia using same, the pharmaceutical composition comprising a therapeutically effective combination of an Fms-like tyrosine kinase-3 (FLT3) inhibitor or pharmaceutically acceptable salt or solvate thereof, and a chemotherapeutic agent or pharmaceutically acceptable salt or solvate thereof.
    Type: Application
    Filed: June 25, 2020
    Publication date: November 10, 2022
    Inventors: In Hwan BAE, Ji Young SONG, Jae Yul CHOI, Young Gil AHN
  • Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
    Patent number: 11292786
    Abstract: Provided are a pyrimidine compound represented by Formula 1, a method of preparing the compound, and a pharmaceutical use of the compound for the prevention or treatment of cancer.
    Type: Grant
    Filed: April 27, 2020
    Date of Patent: April 5, 2022
    Assignee: Hanmi Pharm. Co., Ltd.
    Inventors: In Hwan Bae, Ji Sook Kim, Jae Yul Choi, Seok Jong Kang, Young Gil Ahn, Kwee Hyun Suh
  • IMIDAZOPYRIDINE DERIVATIVE COMPOUNDS AND USE OF SAME
    Publication number: 20220098205
    Abstract: Provided is a compound selected from a compound of chemical formula 1 having lysine-specific demethylase-1 (LSD1) inhibitory activity, and a tautomer, a stereoisomer, and a solvate thereof, and pharmaceutically acceptable salts of the aforementioned components. The compound is effective in the prevention or treatment of diseases caused by abnormal activation of LSD1. Also disclosed is a composition containing the compound as an active ingredient and its uses in preventing and/or treating diseases caused by abnormal activation of LSD1.
    Type: Application
    Filed: January 31, 2020
    Publication date: March 31, 2022
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: In Hwan BAE, Won Jeoung KIM, Ji Sook KIM, Ji Young SONG, Jae Yul CHOI, Min Jeong KIM, Jung Soo NAM, Young Gil AHN
  • Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
    Patent number: 10870639
    Abstract: Provided are a pyrimidine compound represented by Formula 1, a method of preparing the compound, and a pharmaceutical use of the compound for the prevention or treatment of cancer.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: December 22, 2020
    Assignee: HANMI PHARM. CO.. LTD.
    Inventors: In Hwan Bae, Ji Sook Kim, Jae Yul Choi, Seok Jong Kang, Young Gil Ahn, Kwee Hyun Suh
  • PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME
    Publication number: 20200255410
    Abstract: Provided are a pyrimidine compound represented by Formula 1, a method of preparing the compound, and a pharmaceutical use of the compound for the prevention or treatment of cancer.
    Type: Application
    Filed: April 27, 2020
    Publication date: August 13, 2020
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: In Hwan BAE, Ji Sook KIM, Jae Yul CHOI, Seok Jong KANG, Young Gil AHN, Kwee Hyun SUH
  • PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTING OR TREATING CANCERS INCLUDING THE SAME
    Publication number: 20200031806
    Abstract: Provided are a pyrimidine compound represented by Formula 1, a method of preparing the compound, and a pharmaceutical use of the compound for the prevention or treatment of cancer.
    Type: Application
    Filed: April 26, 2019
    Publication date: January 30, 2020
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: In Hwan BAE, Ji Sook KIM, Jae Yul CHOI, Seok Jong KANG, Young Gil AHN, Kwee Hyun SUH
  • Pyrimidine compound and pharmaceutical use thereof
    Patent number: 10519141
    Abstract: Provided are a pyrimidine compound represented by Formula 1, a method of preparing the same, and a pharmaceutical use of the pyrimidine compound for the prevention or treatment of cancer.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: December 31, 2019
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Young Jin Ham, Seok Jong Kang, Jae Yul Choi, Seo Hee Kim, Tae Woo Kim, In Hwan Bae, Young Gil Ahn, Kwee Hyun Suh
  • Pyrimidine compound and pharmaceutical use thereof
    Patent number: 10280154
    Abstract: Provided are a pyrimidine compound represented by Formula 1, a method of preparing the same, and a pharmaceutical use of the pyrimidine compound for the prevention or treatment of cancer.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: May 7, 2019
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Young Jin Ham, Seok Jong Kang, Jae Yul Choi, Seo Hee Kim, Tae Woo Kim, In Hwan Bae, Young Gil Ahn, Kwee Hyun Suh
  • PYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20190127353
    Abstract: Provided are a pyrimidine compound represented by Formula 1, a method of preparing the same, and a pharmaceutical use of the pyrimidine compound for the prevention or treatment of cancer.
    Type: Application
    Filed: December 19, 2018
    Publication date: May 2, 2019
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Young Jin HAM, Seok Jong Kang, Jae Yul Choi, Seo Hee Kim, Tae Woo Kim, In Hwan Bae, Young Gil Ahn, Kwee Hyun Suh
  • PYRIMIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF
    Publication number: 20190031643
    Abstract: Provided are a pyrimidine compound represented by Formula 1, a method of preparing the same, and a pharmaceutical use of the pyrimidine compound for the prevention or treatment of cancer.
    Type: Application
    Filed: September 11, 2018
    Publication date: January 31, 2019
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Young Jin HAM, Seok Jong KANG, Jae Yul CHOI, Seo Hee KIM, Tae Woo KIM, In Hwan BAE, Young Gil AHN, Kwee Hyun SUH
  • Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinases
    Patent number: 8999973
    Abstract: The present invention relates to a thieno[3,2-d]pyrimidine derivative of formula (I), or a pharmaceutically acceptable salt, hydrate or solvate thereof, which has an excellent inhibitory activity on protein kinases, and a pharmaceutical composition comprising the same is effective in preventing or treating abnormal cell growth diseases.
    Type: Grant
    Filed: January 31, 2011
    Date of Patent: April 7, 2015
    Assignees: Hanmi Science Co., Ltd, Korea Institute of Science and Technology, Catholic University Industry Academic Cooperation Foundation
    Inventors: Jung Beom Son, Seung Hyun Jung, Wha II Choi, Young Hee Jung, Jae Yul Choi, Ji Yeon Song, Kyu Hang Lee, Jae Chul Lee, Eun Young Kim, Young Gil Ahn, Maeng Sup Kim, Hwan Geun Choi, Tae Bo Sim, Young Jin Ham, Dong-sik Park, Hwan Kim, Dong-Wook Kim
  • THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY ON PROTEIN KINASES
    Publication number: 20130053370
    Abstract: The present invention relates to a thieno[3,2-d]pyrimidine derivative of formula (I), or a pharmaceutically acceptable salt, hydrate or solvate thereof, which has an excellent inhibitory activity on protein kinases, and a pharmaceutical composition comprising the same is effective in preventing or treating abnormal cell growth diseases.
    Type: Application
    Filed: January 31, 2011
    Publication date: February 28, 2013
    Applicants: HANMI SCIENCE CO., LTD., CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION, KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Jung Beom Son, Seung Hyun Jung, Wha ll Choi, Young Hee Jung, Jae Yul Choi, Ji Yeon Song, Kyu Hang Lee, Jae Chul Lee, Eun Young Kim, Young Gil Ahn, Maeng Sup Kim, Hwan Geun Choi, Tae Bo Sim, Young Jin Ham, Dong-sik Park, Hwan Kim, Dong-Wook Kim